💊 Big Pharma is making big moves.
Vertex Pharmaceuticals just announced a ~$10B all-cash acquisition of Crinetics — its largest deal ever, signaling a major shift beyond its core cystic fibrosis business.
📊 Key highlights:
• $85/share offer — ~102% premium
• Expands into rare endocrine diseases
• Adds approved drug + late-stage pipeline
• Potential >$5B peak annual revenue
📉 Market reaction:
Crinetics surged ~100% overnight
Vertex dipped slightly — a typical response to large acquisitions
✨ Follow us for more latest updates!
#KVB# #TradingNews #Biotech #StockMarket #Investing #MergersAndAcquisitions
已編輯 14 Jul 2026, 10:41
風險提示：本文所述僅代表作者個人觀點，不代表 Followme 的官方立場。Followme 不對內容的準確性、完整性或可靠性作出任何保證，對於基於該內容所採取的任何行為，不承擔任何責任，除非另有書面明確說明。
暫無留言。 來發表第一則觀點吧。